Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD

European Respiratory Journal

Volumn 46, Issue 2, 2015, Pages 336-345

  Van De Bool, Coby ^a   Rutten, Erica P A ^b   Franssen, Frits M E ^b   Wouters, Emiel F M ^a,b   Schols, Annemie M W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CIRO+   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULT; AGED; APPENDICULAR SKELETAL MUSCLE INDEX; ARTICLE; BODY COMPOSITION; BODY MASS; BONE MINERAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; DUTCHMAN; ENDURANCE; FAT MASS; FEMALE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM PARAMETERS; PHYSICAL PERFORMANCE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOPENIA; SEX DIFFERENCE; COMPLICATION; MIDDLE AGED; NETHERLANDS; OBESITY, ABDOMINAL; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; THEORETICAL MODEL; VERY ELDERLY;

C REACTIVE PROTEIN;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NETHERLANDS; OBESITY, ABDOMINAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SARCOPENIA;

EID: 84938826536     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00197314     Document Type: Article

References (37)

1. Vestbo J, Hurd SS, Agust AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5: 647-662.
3. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147: 1151-1156.
4. Rutten EP, Breyer MK, Spruit MA, et al. Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease. Clin Nutr 2010; 29: 756-760.
5. Marquis K, Maltais F, Duguay V, et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005; 25: 226-232.
6. Schols AM, et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 2014; 44: 1504-1520.
7. Engelen MP, Schols AM, Lamers RJ, et al. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 1999; 18: 275-280.
8. Franssen FM, et al. New Reference Values for Body Composition by Bioelectrical Impedance Analysis in the General Population: Results From the UK Biobank. J Am Med Dir Assoc 2014; 15: 448.
9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing 2010; 39: 412-423.
10. Cherin P, Voronska E, Fraoucene N, et al. Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years. Aging Clin Exp Res 2014; 26: 137-146.
11. Chung JH, Hwang HJ, Han CH, et al. Association between Sarcopenia and Metabolic Syndrome in Chronic Obstructive Pulmonary Disease: The Korea National Health and Nutrition Examination Survey (KNHANES) from 2008 to 2011. COPD 2015; 12: 82-89.
12. van de Bool C, Mattijssen-Verdonschot C, van Melick PP, et al. Quality of dietary intake in relation to body composition in patients with chronic obstructive pulmonary disease eligible for pulmonary rehabilitation. Eur J Clin Nutr 2014; 68: 159-165.
13. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82: 53-59.
14. Spruit MA, Vanderhoven-Augustin I, Janssen PP, et al. Integration of pulmonary rehabilitation in COPD. Lancet 2008; 371: 12-13.
15. Clausen JL, Coates AL, Quanjer PH. Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J 1997; 10: 1205-1206.
16. Bjorntorp, P. Regional patterns of fat distribution. Ann Intern Med 1985; 103: 994-995.
17. WHO Scientific Group on the Prevention and Management of Osteoporosis. Prevention and management of osteoporosis; report of a WHO scientific group. 2003. Available from http://whqlibdoc.who.int/trs/who-trs-921.pdf Date last accessed: April 1, 2015.
18. Houben JM, Mercken EM, Ketelslegers HB, et al. Telomere shortening in chronic obstructive pulmonary disease. Respir Med 2009; 103: 230-236.
19. Remels AH, Gosker HR, Langen RC, et al. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol 2013; 114: 1253-1262.
20. Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173: 79-83.
21. Vermeeren MA, Creutzberg EC, Schols AM, et al. Prevalence of nutritional depletion in a large out-patient population of patients with COPD. Respir Med 2006; 100: 1349-1355.
22. Prado CM, Siervo M, Mire E, et al. A population-based approach to define body-composition phenotypes. Am J Clin Nutr 2014; 99: 1369-1377.
23. Baracos VE, Reiman T, Mourtzakis M, et al. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010; 91: 1133S-1137S.
24. Cesari M, Pedone C, Chiurco D, et al. Physical performance, sarcopenia and respiratory function in older patients with chronic obstructive pulmonary disease. Age Ageing 2012; 41: 237-241.
25. Engelen MP, Schols AM, Does JD, et al. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000; 71: 733-738.
26. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153: 976-980.
27. Andrianopoulos V, Wagers SS, Groenen MT, et al. Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD. BMC Pulm Med 2014; 14: 97.
28. Ora J, Laveneziana P, Ofir D, et al. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir Crit Care Med 2009; 180: 964-971.
29. Ora J, Laveneziana P, Wadell K, et al. Effect of obesity on respiratory mechanics during rest and exercise in COPD. J Appl Physiol 2011; 111: 10-19.
30. Sava F, Laviolette L, Bernard S, et al. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med 2010; 10: 55.
31. Laviolette L, Sava F, O'Donnell DE, et al. Effect of obesity on constant workrate exercise in hyperinflated men with COPD. BMC Pulm Med 2010; 10: 33.
32. Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: From sarcopenic obesity to cachexia. Clin Nutr 2014; 33: 737-748.
33. Moon SS. Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocr J 2014; 61: 61-70.
34. van den Borst B, Gosker HR, Koster A, et al. The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease. Am J Clin Nutr 2012; 96: 516-526.
35. Malaguti C, Napolis LM, Villaça D, et al. Relationship between peripheral muscle structure and function in patients with chronic obstructive pulmonary disease with different nutritional status. J Strength Cond Res 2011; 25: 1795-1803.
36. Stephens NA, Gray C, MacDonald AJ, et al. Sexual dimorphism modulates the impact of cancer cachexia on lower limb muscle mass and function. Clin Nutr 2012; 31: 499-505.
37. Palomares MR, Sayre JW, Shekar KC, et al. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 1996; 78: 2119-2126.